Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07777926
PHASE4

Evaluation of Filler Injection for Chin Profile Enhancement

Sponsor: University of Pennsylvania

View on ClinicalTrials.gov

Summary

The goal of this prospective study is to analyze volumetric changes in the lower face after hyaluronic acid filler injections over 90 days. The primary aim of the study is to quantify volume change of the lower face rea over time after injection of filler. The secondary aim is to collect patient related outcomes (PROs) via FACE-Q. Participants will receive hyaluronic acid filler injections (Restylane Lyft(for contouring of the chin. Each patient will receive FDA approved dosages of filler to the lower face region to treat chin regression or chin contouring, as per FDA approved indications. Prior to injections patients will be imaged with 3-dimensional photogrammetry. Subjects will return post-injection in 2 weeks, 1 month, and 3 moths for re-imaging.

Official title: 3-Dimensional Volumetric Analysis of a Hyaluronic Filler Injection for Chin Profile Enhancement

Key Details

Gender

All

Age Range

22 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2026-09-30

Completion Date

2026-12-01

Last Updated

2026-08-20

Healthy Volunteers

Yes

Interventions

DRUG

HA Filler

Patients will receive FDA approved dosages of filler to the lower face region to treat chin regression or contour the chin, as per FDA approved indications. Patients are limited to the maximum recommended injected dose per patient for the initial and re-treatment (touch-up) injections of 4 mL. The injected volume per injection site should not exceed 2mL, the maximum volume studied and established by the manufacturer. Prior to injections, patients will be imaged with 3-dimensional photogrammetry and take a validated survey questionnaire (FACE-Q). Subjects will return post-injection in 2 weeks, 1 month, and 3 months for re-imaging and FACE-Q survey completion.

Locations (1)

Penn Medicine

Philadelphia, Pennsylvania, United States